Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

Home | Back to Search Results

Product Details for NDA 020326

Expand all

NEUTREXIN (TRIMETREXATE GLUCURONATE)
EQ 25MG BASE/VIAL Marketing Status: Discontinued

Active Ingredient: TRIMETREXATE GLUCURONATE
Proprietary Name: NEUTREXIN
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 25MG BASE/VIAL
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N020326
Product Number: 001
Approval Date: Dec 17, 1993
Applicant Holder Full Name: MEDIMMUNE ONCOLOGY INC
Marketing Status:  Discontinued
Patent and Exclusivity Information

NEUTREXIN (TRIMETREXATE GLUCURONATE)
EQ 200MG BASE/VIAL Marketing Status: Discontinued

Active Ingredient: TRIMETREXATE GLUCURONATE
Proprietary Name: NEUTREXIN
Dosage Form; Route of Administration: INJECTABLE; INJECTION
Strength: EQ 200MG BASE/VIAL
Reference Listed Drug: No
Reference Standard: No
TE Code: 
Application Number: N020326
Product Number: 002
Approval Date: Jul 31, 1998
Applicant Holder Full Name: MEDIMMUNE ONCOLOGY INC
Marketing Status:  Discontinued
Patent and Exclusivity Information

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English